CRS Inside Track
Featured Inside Track
The Development of Somatuline Autogel®: An Interview with Joël Richard, Vice President Peptides, Ipsen
By Andy Lewis, CRS Director-at-Large
Somatuline Autogel® is a ready-to-use sustained release formulation of the peptide lanreotide with a unique and innovative controlled release mechanism. Andy Lewis interviewed Joël Richard, VP Peptides at Ipsen, on the background of its development, how it works, and how it is manufactured.